Fairvalue-Calculator Fairvalue-Calculator
EN DE

Perfect Medical Industry Co (6543) Fair Value & Analysis

Healthcare · TW · Market cap 1.1B TWD

Price19.40 TWD
Fair Value15.05 TWD
Upside-22.4%
Quality95/100
Evidence: High Range 11.54 TWD – 19.56 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Perfect Medical Industry Co (6543) currently trades at 19.40 TWD, while our model-based Fair Value estimate is 15.05 TWD — implying the stock looks roughly 22.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally. It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes. The company also offers its products under the PF brand in Asia, Africa, Europe, and South America. Perfect Medical Industry Co., Ltd. was founded in 1989 and is headquartered in Changhua, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Perfect Medical Industry Co (6543) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 15.05 TWD versus a price of 19.40 TWD — about −22% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6543?
Our 21-model fair value for Perfect Medical Industry Co is 15.05 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 19.40 TWD.
What is the quality score of 6543?
Perfect Medical Industry Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.